Pathway Financial Advisers’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $437K | Sell |
9,432
-89
| -0.9% | -$4.12K | 0.14% | 131 |
|
|
2025
Q1 | $581K | Buy |
9,521
+487
| +5% | +$29.7K | 0.2% | 115 |
|
|
2024
Q4 | $511K | Sell |
9,034
-422,078
| -98% | -$23.9M | 0.17% | 124 |
|
|
2024
Q3 | $8.33K | Buy |
431,112
+429,992
| +38,392% | +$8.31K | ﹤0.01% | 306 |
|
|
2024
Q2 | $46.5K | Buy |
1,120
+16
| +1% | +$664 | 0.02% | 233 |
|
|
2024
Q1 | $59.9K | Sell |
1,104
-27,204
| -96% | -$1.48M | 0.02% | 216 |
|
|
2023
Q4 | $1.45M | Sell |
28,308
-3,332
| -11% | -$171K | 0.55% | 64 |
|
|
2023
Q3 | $1.84M | Buy |
+31,640
| New | +$1.84M | 0.76% | 44 |
|
|
2023
Q1 | $2.2M | Buy |
31,686
+2
| +0% | +$139 | 0.88% | 36 |
|
|
2022
Q4 | $2.28M | Buy |
+31,684
| New | +$2.28M | 0.92% | 33 |
|